03759 PHARMARON
- 9.250
- -0.580-5.90%
PHARMARON News
PHARMARON: An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
PHARMARON: An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
PHARMARON: Next Day Disclosure Return
PHARMARON: Announcement of the 8th Meeting of the Third Board of Directors of Kanglong Huazheng (Beijing) New Drug Technology Co., Ltd.
PHARMARON: VOLUNTARY ANNOUNCEMENT DISPOSAL OF EQUITY INTERESTS IN OVERSEAS MINORITY INVESTMENT OF THE COMPANY
PHARMARON: Next Day Disclosure Return
(UPDATED) FINAL DIVIDEND IN CASH FOR THE YEAR ENDED DECEMBER 31, 2023
Notification Letter and Request Form to Non-registered Shareholders - Notification of publication of Circular and Notice of the 2023 Annual General Meeting and 2024 First H Share Class Meeting
Notification Letter and Request Form to H Shareholders - Notification of publication of Circular, Notice and Proxy Form for the 2023 Annual General Meeting and 2024 First H Share Class Meeting
Form of Proxy for the First H Share Class Meeting of 2024
Form of Proxy for the Annual General Meeting of 2023 (Applicable to H Shareholders)
PHARMARON: Announcement on the Initial Repurchase of Company Shares, Kanglong Huazheng (Beijing) New Drug Technology Co., Ltd.
PHARMARON: Next Day Disclosure Return
PHARMARON: Changlong Huacheng (Beijing) New Drug Technology Co., Ltd. Announcement on Progress of Repurchase of Company Shares
PHARMARON: Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2024
PHARMARON: Report on Repurchase of Shares of Kanglong Huacheng (Beijing) New Drug Technology Co., Ltd., Announcement on the Status of the Top Ten Shareholders and the Top Ten Unlimited Sale Shareholders on Repurchase Matters
Notification Letter and Request Form to Non-registered holders - Notice of Publication of 2023 Annual Report and 2023 Environmental, Social and Governance Report
Notification Letter and Request Form to H Shareholders - Notice of Publication of 2023 Annual Report and 2023 Environmental, Social and Governance Report
2023 Environmental, Social and Governance Report
PHARMARON: Announcement of Resolution of the Seventh Meeting of the Third Board of Directors of Kanglong Huacheng (Beijing) New Drug Technology Co., Ltd.
Analysis
Price Target
No Data
